Medtech stories we missed this week: April 14, 2017

From FDA approvals to business expansion plans, here are medtech stories we missed this week but thought were still worth mentioning. 1. BioTelemetry launches offer to acquire LifeWatch BioTelemetry and LifeWatch announced in an April 9 press release that the 2 companies have entered a transaction agreement that states BioTelemetry will launch a tender offer to acquire all

3 new wound dressings you should know

Surgical dressings are designed to control post-operation bleeding, absorb exudate, ease pain and provide protection for the wound, according to an article relayed by the National Center for Biotechnology Information. If properly taken care of, surgical dressings prevent surgical site infections. According to Johns Hopkins Medicine, the chances of developing a post-surgical wound infection ranges from

The top medtech stories of early 2017

The new Trump administration and Republican Congress – and all the accompanying change and uncertainty –is the major story for the medical device industry. But there are many other medtech stories worth noting from the first quarter of 2017. There was an FDA warning over Abbott’s Absorb bioresorbable stent, a continued spate of M&A deals, a

Pages: 1 2 3 4 5 6

Acelity introduces ALLODERM SELECT DUO Regenerative Tissue Matrix

Acelity, a global advanced wound care and regenerative medicine company, announced that ALLODERM SELECT DUOTM Regenerative Tissue Matrix is now available in the U.S. ALLODERM Regenerative Tissue Matrix is a biological tissue matrix for soft tissue reinforcement in breast reconstruction procedures, with more than 1.4 million implants to date. The new offering is a matched tissue